Introduction: Enzyme definition, Composition: Protein part Apoprotein)/Non-protein(cofactors/coenzymes)
Applications, Enzyme Nomenclature
Basic Structure of Enzyme
Homo-multimers
Hetero-multimers
Multiple Forms of Enzymes
Origins of Enzyme Variants: Genetic and Non-genetic
Example of Genetic and Non-genetic
Iso-enzymes: Examples
Specificity of Enzymes
Multifunctional enzymes contain two or more distinct catalytic activities located in a single polypeptide chain. Fatty acid synthase is a multifunctional enzyme that synthesizes fatty acids through seven distinct enzymatic activities located on three functional domains. DNA polymerase is another multifunctional enzyme that synthesizes DNA and proofreads for errors through its polymerase and exonuclease activities.
This document provides information about enzymes, including their properties, classification, and roles in biochemical processes and medicine. Some key points:
- Enzymes are proteins that catalyze chemical reactions in living cells without being consumed in the process. They work by lowering the activation energy of reactions.
- There are six major classes of enzymes based on the type of reaction catalyzed: oxidoreductases, transferases, hydrolases, lyases, isomerases, and ligases.
- Enzymes require cofactors like metal ions or organic coenzymes derived from vitamins to function. The active holoenzyme is made up of an apoenzyme and its cofactors.
-
- Glycoproteins are proteins that contain oligosaccharide chains covalently attached to their polypeptide backbones. They serve important biological roles.
- There are two main classes of glycoproteins: O-linked, where sugars attach to serine or threonine residues, and N-linked, where sugars attach to asparagine residues.
- Diseases can result from defects in glycoprotein biosynthesis, such as I-cell disease caused by a defect in N-linked glycosylation and congenital disorders of glycosylation caused by various defects impacting O-linked or N-linked glycosylation.
Anomers are carbohydrate structures that differ only in the configuration of the hydroxyl group on the anomeric carbon. The anomeric carbon is the carbon atom involved in the cyclic formation of carbohydrates. Examples of anomers are alpha-glucose and beta-glucose which have different hydroxyl group positions on the first carbon. Epimers differ at only one other chiral carbon, not the anomeric carbon, while mutarotation is the process where glucose anomers interconvert between ring forms in solution.
This document provides an overview of allosteric enzymes. It defines allosteric enzymes as enzymes whose activity is regulated by the binding of allosteric effectors at sites other than the active site. There are two types of allosteric effectors - positive effectors that increase enzyme activity and negative effectors that decrease it. Allosteric enzymes display cooperative binding and sigmoidal kinetics. They are classified as K-class or V-class depending on whether the effector changes the Km or Vmax value. Models like the Monod-Wyman-Changeux model and Koshland-Nemethy-Filmer model are described as proposed mechanisms for allosteric regulation. Aspartate transcarbamoylase
This document discusses isoenzymes, which are physically distinct forms of the same enzyme that catalyze the same biochemical reaction. Isoenzymes can be identified through properties like electrophoresis, heat stability, inhibitor sensitivity, and tissue localization. The document outlines how isoenzymes help in medical diagnosis and prognosis by examining levels of enzymes like lactate dehydrogenase, creatine kinase, and alkaline phosphatase that are elevated in conditions like myocardial infarction, muscular dystrophy, and liver disease. Specific isoenzyme patterns can provide information about damaged tissues. The therapeutic uses of some enzymes are also mentioned.
Multifunctional enzymes contain two or more distinct catalytic activities located in a single polypeptide chain. Fatty acid synthase is a multifunctional enzyme that synthesizes fatty acids through seven distinct enzymatic activities located on three functional domains. DNA polymerase is another multifunctional enzyme that synthesizes DNA and proofreads for errors through its polymerase and exonuclease activities.
This document provides information about enzymes, including their properties, classification, and roles in biochemical processes and medicine. Some key points:
- Enzymes are proteins that catalyze chemical reactions in living cells without being consumed in the process. They work by lowering the activation energy of reactions.
- There are six major classes of enzymes based on the type of reaction catalyzed: oxidoreductases, transferases, hydrolases, lyases, isomerases, and ligases.
- Enzymes require cofactors like metal ions or organic coenzymes derived from vitamins to function. The active holoenzyme is made up of an apoenzyme and its cofactors.
-
- Glycoproteins are proteins that contain oligosaccharide chains covalently attached to their polypeptide backbones. They serve important biological roles.
- There are two main classes of glycoproteins: O-linked, where sugars attach to serine or threonine residues, and N-linked, where sugars attach to asparagine residues.
- Diseases can result from defects in glycoprotein biosynthesis, such as I-cell disease caused by a defect in N-linked glycosylation and congenital disorders of glycosylation caused by various defects impacting O-linked or N-linked glycosylation.
Anomers are carbohydrate structures that differ only in the configuration of the hydroxyl group on the anomeric carbon. The anomeric carbon is the carbon atom involved in the cyclic formation of carbohydrates. Examples of anomers are alpha-glucose and beta-glucose which have different hydroxyl group positions on the first carbon. Epimers differ at only one other chiral carbon, not the anomeric carbon, while mutarotation is the process where glucose anomers interconvert between ring forms in solution.
This document provides an overview of allosteric enzymes. It defines allosteric enzymes as enzymes whose activity is regulated by the binding of allosteric effectors at sites other than the active site. There are two types of allosteric effectors - positive effectors that increase enzyme activity and negative effectors that decrease it. Allosteric enzymes display cooperative binding and sigmoidal kinetics. They are classified as K-class or V-class depending on whether the effector changes the Km or Vmax value. Models like the Monod-Wyman-Changeux model and Koshland-Nemethy-Filmer model are described as proposed mechanisms for allosteric regulation. Aspartate transcarbamoylase
This document discusses isoenzymes, which are physically distinct forms of the same enzyme that catalyze the same biochemical reaction. Isoenzymes can be identified through properties like electrophoresis, heat stability, inhibitor sensitivity, and tissue localization. The document outlines how isoenzymes help in medical diagnosis and prognosis by examining levels of enzymes like lactate dehydrogenase, creatine kinase, and alkaline phosphatase that are elevated in conditions like myocardial infarction, muscular dystrophy, and liver disease. Specific isoenzyme patterns can provide information about damaged tissues. The therapeutic uses of some enzymes are also mentioned.
Enzymes use several catalytic mechanisms to lower the free energy of transition states and greatly increase reaction rates, including acid-base catalysis, covalent catalysis, metal ion catalysis, and bringing substrates into close proximity and proper orientation. Acid-base catalysis involves proton transfer from catalytic amino acid side chains. Covalent catalysis transiently forms covalent bonds between enzyme and substrate. Metal ion catalysis uses transition metals to orient substrates, mediate redox reactions, or stabilize charges. Proximity and orientation align substrates for reaction, while catalysis by approximation brings two substrates together for reaction.
Creatine kinase (CK) and lactate dehydrogenase (LDH) are important isoenzymes that can help diagnose conditions like acute myocardial infarction. CK has three isoenzymes - CK-BB in the brain, CK-MB in cardiac muscle (80% of total), and CK-MM in skeletal muscle (94-100% of normal serum). Increased CK-MB more than 6% of total CK indicates AMI. LDH has five isoenzymes - LD1 highest in heart and LD5 in skeletal muscle. Elevated LD1 and flipped LD1>LD2 pattern indicates AMI. Aspartate aminotransferase (AST) also rises with AMI and
Industrial and clinical (medical) applications of enzymes ppt dr. r. mallikamallikaswathi
The document discusses several industrial and clinical applications of enzymes. It describes how enzymes are used in industries like biofuels, detergents, brewing, food processing, paper, and personal care. It also outlines how certain enzymes like alkaline phosphatase, creatine kinase, alanine aminotransferase, aspartate aminotransferase, and others are used as diagnostic markers for diseases in humans and animals. The document further discusses how enzymes are used therapeutically, for example streptokinase to clear blood clots, asparaginase in leukemia treatment, and enzyme replacement therapy for genetic deficiencies.
Inborn errors of protein metabolism occur from genetic disorders that cause defects in enzymes involved in biochemical pathways that break down food components normally. Some key points:
1. Genetic disorders are categorized as chromosomal, monogenic, or complex/multifactorial disorders. Inborn errors of metabolism fall under monogenic disorders caused by single gene defects.
2. Examples of inborn errors include disorders of the urea cycle like ornithine transcarbamylase deficiency and disorders of amino acid metabolism like phenylketonuria, alkaptonuria, and maple syrup urine disease.
3. Symptoms of newborns with urea cycle defects include lethargy, coma, seizures,
This document discusses the diagnostic importance of enzymes and isoenzymes. It provides information on functional and non-functional enzymes, how isoenzymes are formed, methods to identify isoenzymes, examples of important isoenzymes like lactate dehydrogenase and creatine phosphokinase, alkaline phosphatase, and changes in enzyme levels related to conditions like myocardial infarction, liver disease, and acute pancreatitis. Overall, it outlines how measuring specific enzymes and isoenzymes can provide clinically useful information for diagnosing tissue damage and certain medical conditions.
Enzyme structure and Mechanism of Action Swati Raysing
This document discusses enzyme structure and mechanism of action. It defines enzymes as specialized proteins that catalyze biochemical reactions by lowering activation energy. Enzymes play important roles in metabolism, diagnosis, and therapeutics. The active site of an enzyme is where substrate binds. Enzymes use cofactors like coenzymes and prosthetic groups to function. Reaction rates depend on factors like substrate/enzyme concentration, temperature, pH, and presence of activators. Enzymes work via lock-and-key or induced fit models to form enzyme-substrate complexes and reduce activation energy of reactions.
The flux of metabolites through metabolic pathways involves
catalysis by numerous enzymes. Active control of homeostasis is achieved by the regulation of only a small number of enzymes.
Allosteric enzymes can be regulated by effector molecules that bind at sites other than the active site. This binding can increase or decrease the enzyme's affinity for substrates or maximal catalytic activity. There are two classes of allosteric enzymes - K-series where the effector increases Km without affecting Vmax, and V-series where the effector decreases Vmax without affecting Km. Effectors can also cause allosteric enzymes to display sigmoidal reaction velocity curves rather than standard Michaelis-Menten hyperbolic curves. Covalent modifications like phosphorylation can also regulate enzymatic activity by increasing or decreasing the enzyme's activity.
Lactate dehydrogenase (LDH) is an enzyme that catalyzes the conversion of lactate to pyruvate. It exists as five isoenzymes (LDH-1 to LDH-5) that differ in their subunit composition and electric charge. The isoenzymes show varying tissue distribution, catalytic properties, and clinical significance. Elevated levels of specific isoenzymes can help identify the origin of tissue damage, as LDH-1 and LDH-2 indicate myocardial infarction while LDH-4 and LDH-5 signify liver damage. The LDH isoenzyme pattern also provides information about different cancer types.
Sphingolipids are a class of lipids that include sphingomyelin, glycosphingolipids, and ceramide. They serve important structural and signaling functions in the cell membrane and participate in processes like cell growth, differentiation, and apoptosis. Sphingolipids are synthesized through de novo pathways or through the breakdown of sphingomyelin. Their metabolites, including ceramide, sphingosine-1-phosphate, and gangliosides act as second messengers and influence pathways such as PI3K/Akt and JNK. Sphingolipids are also components of lipid rafts and caveolae, which regulate protein activity and cellular signaling. Imbalances in sph
The document discusses amino acid metabolism. It begins by outlining the major pathways of amino acid metabolism, including transamination, deamination, and decarboxylation. These pathways allow amino acids to be used for protein synthesis, energy production, and the formation of other nitrogenous compounds. The urea cycle is also summarized, which involves several steps to produce urea from ammonia in the liver. Finally, some specific amino acids like glycine are discussed in more detail regarding their catabolism. In general, the carbon skeletons of amino acids enter central metabolic pathways while the amino groups are removed as ammonia and ultimately excreted as urea.
Biosynthesis and degradation of porphyrin and hemesountharya Sen s
This document summarizes the biosynthesis and degradation of porphyrin and heme. It discusses how glycine and succinyl CoA are condensed to form δ-aminolevulinate, the starting material for porphyrin synthesis. Four molecules of porphobilinogen then condense to form the porphyrin ring. A series of reactions incorporates iron to form heme. Heme is degraded through heme oxygenase to form biliverdin and bilirubin, which is transported to the liver bound to albumin.
The document discusses the Hill equation, which was formulated by Archibald Hill in 1910 to describe the sigmoidal oxygen binding curve of hemoglobin. The Hill equation can be used to describe the fraction of a macromolecule saturated by a ligand as a function of the ligand's concentration. It is useful for determining the degree of cooperativity between ligand binding sites. A Hill coefficient of n > 1 indicates positively cooperative binding, n < 1 indicates negatively cooperative binding, and n = 1 indicates noncooperative binding.
Isoenzymes are multiple forms of enzymes that arise from genetically determined differences in primary structure. Isoforms arise from post-translational modifications. Lactate dehydrogenase (LDH), creatine kinase (CK), alkaline phosphatase (ALP), and acid phosphatase (ACP) are clinically important enzymes that exist as isoenzymes. LDH isoenzymes can indicate tissue damage like myocardial infarction. CK isoenzymes are measured to detect heart attacks. ALP isoenzymes are elevated in bone and liver diseases. Isoenzyme patterns are determined through properties like electrophoretic mobility, heat stability, and inhibitor response.
Enzymes are protein catalysts that speed up biochemical reactions without being consumed. They achieve specificity and efficiency through their active sites, which bind substrates and use mechanisms like proximity, acid/base catalysis, and covalent bonding to facilitate reactions. Enzyme activity can be measured and is affected by factors like temperature, pH, substrate and enzyme concentration. The Michaelis-Menten model describes the hyperbolic relationship between reaction rate and substrate concentration. Kinetic analysis allows determination of parameters like Km and Vmax. Inhibitors are used clinically and in research to reduce reaction rates by binding in or near the active site.
This ppt describes the overview of enzyme regulation and Allosterism. Presented since October 23,2017GC at Addis Ababa University, School of Medicine, Department of medical biochemistry.
Enzymes are biological catalysts that speed up chemical reactions without being consumed. Their activity can be measured by determining the amount of substrate converted to product per unit time. There are two main types of enzyme assays: continuous assays that measure reaction rates over time, and discontinuous assays that take samples at intervals to measure substrate/product levels. Common techniques to measure enzyme activity include spectrophotometry, fluorescence spectroscopy, chromatography, and radiometric methods. Spectrophotometry is often used to examine light absorption of substrates and products in the ultraviolet-visible range.
Amino acid metabolism involves several key reactions: transamination, deamination, and the urea cycle. Transamination is the transfer of amino groups between amino acids via pyridoxal phosphate. Deamination removes amino groups via oxidative or non-oxidative pathways, producing ammonia. The liver's urea cycle converts ammonia into urea for excretion to detoxify ammonia. Disorders of the urea cycle can cause high ammonia levels and neurological issues if not treated. Amino acids undergo breakdown and synthesis to form proteins, peptides, and other nitrogenous compounds essential for cellular metabolism and function.
Enzymes are biological catalysts that are essential for life. They catalyze biochemical reactions efficiently and selectively. Enzymes lower the activation energy of reactions, increasing their rate. Most enzymes are proteins that use their tertiary structure and amino acid residues within their active site to catalyze reactions. The active site facilitates reactions by bringing substrates close together, stabilizing transition states, and using mechanisms like acid-base catalysis. This allows reactions to proceed rapidly under mild biological conditions. Without enzymes, reactions in living organisms would not occur at a useful pace to sustain life.
Enzymes are protein catalysts that accelerate chemical reactions in living organisms. They facilitate reactions by lowering the activation energy needed. Enzymes achieve specificity through their active sites, which are complementary in shape and chemical properties to their substrates. Factors like temperature, pH, and inhibitors can impact an enzyme's activity. There are several mechanisms of enzyme action and regulation, including competitive and non-competitive inhibition, as well as allosteric regulation through effectors binding at distinct sites. Precise control of enzymes is crucial for metabolic processes in cells and organisms.
Enzymes use several catalytic mechanisms to lower the free energy of transition states and greatly increase reaction rates, including acid-base catalysis, covalent catalysis, metal ion catalysis, and bringing substrates into close proximity and proper orientation. Acid-base catalysis involves proton transfer from catalytic amino acid side chains. Covalent catalysis transiently forms covalent bonds between enzyme and substrate. Metal ion catalysis uses transition metals to orient substrates, mediate redox reactions, or stabilize charges. Proximity and orientation align substrates for reaction, while catalysis by approximation brings two substrates together for reaction.
Creatine kinase (CK) and lactate dehydrogenase (LDH) are important isoenzymes that can help diagnose conditions like acute myocardial infarction. CK has three isoenzymes - CK-BB in the brain, CK-MB in cardiac muscle (80% of total), and CK-MM in skeletal muscle (94-100% of normal serum). Increased CK-MB more than 6% of total CK indicates AMI. LDH has five isoenzymes - LD1 highest in heart and LD5 in skeletal muscle. Elevated LD1 and flipped LD1>LD2 pattern indicates AMI. Aspartate aminotransferase (AST) also rises with AMI and
Industrial and clinical (medical) applications of enzymes ppt dr. r. mallikamallikaswathi
The document discusses several industrial and clinical applications of enzymes. It describes how enzymes are used in industries like biofuels, detergents, brewing, food processing, paper, and personal care. It also outlines how certain enzymes like alkaline phosphatase, creatine kinase, alanine aminotransferase, aspartate aminotransferase, and others are used as diagnostic markers for diseases in humans and animals. The document further discusses how enzymes are used therapeutically, for example streptokinase to clear blood clots, asparaginase in leukemia treatment, and enzyme replacement therapy for genetic deficiencies.
Inborn errors of protein metabolism occur from genetic disorders that cause defects in enzymes involved in biochemical pathways that break down food components normally. Some key points:
1. Genetic disorders are categorized as chromosomal, monogenic, or complex/multifactorial disorders. Inborn errors of metabolism fall under monogenic disorders caused by single gene defects.
2. Examples of inborn errors include disorders of the urea cycle like ornithine transcarbamylase deficiency and disorders of amino acid metabolism like phenylketonuria, alkaptonuria, and maple syrup urine disease.
3. Symptoms of newborns with urea cycle defects include lethargy, coma, seizures,
This document discusses the diagnostic importance of enzymes and isoenzymes. It provides information on functional and non-functional enzymes, how isoenzymes are formed, methods to identify isoenzymes, examples of important isoenzymes like lactate dehydrogenase and creatine phosphokinase, alkaline phosphatase, and changes in enzyme levels related to conditions like myocardial infarction, liver disease, and acute pancreatitis. Overall, it outlines how measuring specific enzymes and isoenzymes can provide clinically useful information for diagnosing tissue damage and certain medical conditions.
Enzyme structure and Mechanism of Action Swati Raysing
This document discusses enzyme structure and mechanism of action. It defines enzymes as specialized proteins that catalyze biochemical reactions by lowering activation energy. Enzymes play important roles in metabolism, diagnosis, and therapeutics. The active site of an enzyme is where substrate binds. Enzymes use cofactors like coenzymes and prosthetic groups to function. Reaction rates depend on factors like substrate/enzyme concentration, temperature, pH, and presence of activators. Enzymes work via lock-and-key or induced fit models to form enzyme-substrate complexes and reduce activation energy of reactions.
The flux of metabolites through metabolic pathways involves
catalysis by numerous enzymes. Active control of homeostasis is achieved by the regulation of only a small number of enzymes.
Allosteric enzymes can be regulated by effector molecules that bind at sites other than the active site. This binding can increase or decrease the enzyme's affinity for substrates or maximal catalytic activity. There are two classes of allosteric enzymes - K-series where the effector increases Km without affecting Vmax, and V-series where the effector decreases Vmax without affecting Km. Effectors can also cause allosteric enzymes to display sigmoidal reaction velocity curves rather than standard Michaelis-Menten hyperbolic curves. Covalent modifications like phosphorylation can also regulate enzymatic activity by increasing or decreasing the enzyme's activity.
Lactate dehydrogenase (LDH) is an enzyme that catalyzes the conversion of lactate to pyruvate. It exists as five isoenzymes (LDH-1 to LDH-5) that differ in their subunit composition and electric charge. The isoenzymes show varying tissue distribution, catalytic properties, and clinical significance. Elevated levels of specific isoenzymes can help identify the origin of tissue damage, as LDH-1 and LDH-2 indicate myocardial infarction while LDH-4 and LDH-5 signify liver damage. The LDH isoenzyme pattern also provides information about different cancer types.
Sphingolipids are a class of lipids that include sphingomyelin, glycosphingolipids, and ceramide. They serve important structural and signaling functions in the cell membrane and participate in processes like cell growth, differentiation, and apoptosis. Sphingolipids are synthesized through de novo pathways or through the breakdown of sphingomyelin. Their metabolites, including ceramide, sphingosine-1-phosphate, and gangliosides act as second messengers and influence pathways such as PI3K/Akt and JNK. Sphingolipids are also components of lipid rafts and caveolae, which regulate protein activity and cellular signaling. Imbalances in sph
The document discusses amino acid metabolism. It begins by outlining the major pathways of amino acid metabolism, including transamination, deamination, and decarboxylation. These pathways allow amino acids to be used for protein synthesis, energy production, and the formation of other nitrogenous compounds. The urea cycle is also summarized, which involves several steps to produce urea from ammonia in the liver. Finally, some specific amino acids like glycine are discussed in more detail regarding their catabolism. In general, the carbon skeletons of amino acids enter central metabolic pathways while the amino groups are removed as ammonia and ultimately excreted as urea.
Biosynthesis and degradation of porphyrin and hemesountharya Sen s
This document summarizes the biosynthesis and degradation of porphyrin and heme. It discusses how glycine and succinyl CoA are condensed to form δ-aminolevulinate, the starting material for porphyrin synthesis. Four molecules of porphobilinogen then condense to form the porphyrin ring. A series of reactions incorporates iron to form heme. Heme is degraded through heme oxygenase to form biliverdin and bilirubin, which is transported to the liver bound to albumin.
The document discusses the Hill equation, which was formulated by Archibald Hill in 1910 to describe the sigmoidal oxygen binding curve of hemoglobin. The Hill equation can be used to describe the fraction of a macromolecule saturated by a ligand as a function of the ligand's concentration. It is useful for determining the degree of cooperativity between ligand binding sites. A Hill coefficient of n > 1 indicates positively cooperative binding, n < 1 indicates negatively cooperative binding, and n = 1 indicates noncooperative binding.
Isoenzymes are multiple forms of enzymes that arise from genetically determined differences in primary structure. Isoforms arise from post-translational modifications. Lactate dehydrogenase (LDH), creatine kinase (CK), alkaline phosphatase (ALP), and acid phosphatase (ACP) are clinically important enzymes that exist as isoenzymes. LDH isoenzymes can indicate tissue damage like myocardial infarction. CK isoenzymes are measured to detect heart attacks. ALP isoenzymes are elevated in bone and liver diseases. Isoenzyme patterns are determined through properties like electrophoretic mobility, heat stability, and inhibitor response.
Enzymes are protein catalysts that speed up biochemical reactions without being consumed. They achieve specificity and efficiency through their active sites, which bind substrates and use mechanisms like proximity, acid/base catalysis, and covalent bonding to facilitate reactions. Enzyme activity can be measured and is affected by factors like temperature, pH, substrate and enzyme concentration. The Michaelis-Menten model describes the hyperbolic relationship between reaction rate and substrate concentration. Kinetic analysis allows determination of parameters like Km and Vmax. Inhibitors are used clinically and in research to reduce reaction rates by binding in or near the active site.
This ppt describes the overview of enzyme regulation and Allosterism. Presented since October 23,2017GC at Addis Ababa University, School of Medicine, Department of medical biochemistry.
Enzymes are biological catalysts that speed up chemical reactions without being consumed. Their activity can be measured by determining the amount of substrate converted to product per unit time. There are two main types of enzyme assays: continuous assays that measure reaction rates over time, and discontinuous assays that take samples at intervals to measure substrate/product levels. Common techniques to measure enzyme activity include spectrophotometry, fluorescence spectroscopy, chromatography, and radiometric methods. Spectrophotometry is often used to examine light absorption of substrates and products in the ultraviolet-visible range.
Amino acid metabolism involves several key reactions: transamination, deamination, and the urea cycle. Transamination is the transfer of amino groups between amino acids via pyridoxal phosphate. Deamination removes amino groups via oxidative or non-oxidative pathways, producing ammonia. The liver's urea cycle converts ammonia into urea for excretion to detoxify ammonia. Disorders of the urea cycle can cause high ammonia levels and neurological issues if not treated. Amino acids undergo breakdown and synthesis to form proteins, peptides, and other nitrogenous compounds essential for cellular metabolism and function.
Enzymes are biological catalysts that are essential for life. They catalyze biochemical reactions efficiently and selectively. Enzymes lower the activation energy of reactions, increasing their rate. Most enzymes are proteins that use their tertiary structure and amino acid residues within their active site to catalyze reactions. The active site facilitates reactions by bringing substrates close together, stabilizing transition states, and using mechanisms like acid-base catalysis. This allows reactions to proceed rapidly under mild biological conditions. Without enzymes, reactions in living organisms would not occur at a useful pace to sustain life.
Enzymes are protein catalysts that accelerate chemical reactions in living organisms. They facilitate reactions by lowering the activation energy needed. Enzymes achieve specificity through their active sites, which are complementary in shape and chemical properties to their substrates. Factors like temperature, pH, and inhibitors can impact an enzyme's activity. There are several mechanisms of enzyme action and regulation, including competitive and non-competitive inhibition, as well as allosteric regulation through effectors binding at distinct sites. Precise control of enzymes is crucial for metabolic processes in cells and organisms.
Enzymes are biological catalysts that speed up biochemical reactions without being consumed. They achieve high catalytic efficiency by lowering the activation energy of reactions. Enzymes are usually highly specific and function by binding substrates and facilitating the formation of enzyme-substrate complexes. Many enzymes require non-protein cofactors like metal ions, coenzymes, or prosthetic groups to function. Reaction rates carried out by enzymes can be affected by factors like substrate concentration, temperature, pH, and inhibitors. Enzymes play essential roles in cellular metabolism and are regulated through various mechanisms to control metabolic pathways.
Unit 4: Plasma Enzyme tests in diagnosis DrElhamSharif
This document provides an overview of plasma enzyme tests and their use in diagnosis. It discusses factors that affect enzyme reaction rates, the clinical usefulness of measuring serum enzyme levels, and specific enzymes that are useful in diagnosing various disorders, including cardiac, hepatic, bone, muscle, malignancies and acute pancreatitis. The document also covers enzyme kinetics, the advantages and disadvantages of enzyme assays, how enzyme activity is measured and calculated, and the classification of different enzyme types.
This document provides an overview of enzymes and their properties. It discusses:
- The history of enzyme discovery and early debates about fermentation
- That enzymes are proteins that catalyze metabolic reactions in cells
- Key properties of enzymes including that they are catalysts, require small amounts, and are not consumed in reactions
- The importance of enzymes in cellular processes and their medical applications such as diagnosing disease
- How enzymes accelerate reactions by reducing activation energy without changing reaction thermodynamics or products
- General properties of enzymes like substrate specificity, effect of temperature and pH on activity, and being proteinaceous
This document defines enzymes and describes their key characteristics. It states that enzymes are biological catalysts that speed up chemical reactions without being used up in the process. The document outlines several models of enzyme action, including the lock-and-key and induced fit models. It also discusses factors that can affect an enzyme's activity, such as substrate concentration, temperature, and pH. Finally, it describes how enzymes are classified and their high specificity for particular reactions and substrates.
This document discusses enzymes and their properties. It begins by explaining that enzymes are biological catalysts that are usually proteins and that speed up biochemical reactions. It describes enzyme structure, including the active site where substrates bind. It discusses cofactors that enzymes require to function properly. The document then explains enzyme kinetics concepts like Michaelis-Menten kinetics and how temperature, pH, and substrate concentration affect reaction rates. Finally, it covers inhibition, where inhibitors bind enzymes and decrease their activity, and activation, where enzymes are converted to more active forms.
5. Biochemistry of enzymes edited 2024.pptxmohammed959032
Enzymes are biological catalysts that regulate biochemical reactions. This document discusses the composition, mechanisms, and factors that influence enzyme activity. It describes how enzymes lower activation energy and use an active site to bind substrates and stabilize reaction intermediates. The Michaelis-Menten equation models how reaction rate varies with substrate concentration in relation to parameters like Vmax and Km. Environmental factors like temperature and pH can impact enzyme activity.
This document discusses enzymes and provides information on their chemistry, classification, mechanism of action, kinetics, inhibition, activation and specificity. It defines enzymes as biological catalysts that speed up biochemical reactions. Most enzymes are globular proteins that contain an active site for substrate binding. The document outlines different types of enzyme kinetics including effects of temperature, pH, and substrate concentration. It also describes different types of inhibition like competitive, non-competitive and irreversible inhibition. Activation of enzymes by cofactors is also summarized.
Enzymes are protein catalysts that support biochemical reactions in cells and tissues. They have active sites that substrates must fit into in order to undergo reaction. Enzymes are classified based on their reactions and components. Some require coenzymes like B vitamins or metal ions. Enzyme activity is affected by factors like substrate, enzyme, and product concentration; temperature; pH; and presence of activators or inhibitors. Clinical enzyme tests can indicate tissue damage, such as elevated liver enzymes in hepatitis or muscle enzymes in infarction. Together with other markers, enzymes help diagnose and monitor various conditions.
Enzymes are protein catalysts that accelerate biochemical reactions without being consumed. They achieve high specificity and reaction rates by lowering the activation energy of reactions. Enzymes are classified based on the type of reaction they catalyze and identified by EC numbers. Many factors influence enzyme activity, including temperature, pH, and substrate concentration. Enzymes precisely bind substrates in their active sites to form enzyme-substrate complexes that stabilize transition states and yield products.
This document discusses biocatalysts and enzymes. It begins by listing five properties of useful industrial microbes, such as producing spores or being amenable to genetic manipulation. It then defines biocatalysts as enzymes or microbes that accelerate chemical reactions. Enzymes function as biocatalysts by lowering the activation energy of reactions. The document outlines the structure and function of enzymes, including their active sites, and compares enzymes to non-biological catalysts. It also discusses producing biocatalysts through fermentation and engineering enzymes to modify their properties.
Enzymes are proteins that act as biological catalysts, regulating the rate of chemical reactions in living organisms. They accelerate reactions by lowering the activation energy without being consumed in the process. Enzymes are highly specific and each enzyme catalyzes only one type of reaction. They are affected by factors like temperature, pH, and substrate concentration. The active site of the enzyme binds specifically to substrates and catalyzes the conversion of substrates to products. Enzymes play essential roles in processes like digestion, cellular metabolism, and protection against pathogens.
An enzyme is a biological catalyst and is almost always a protein. It speeds up the rate of a specific chemical reaction in the cell. The enzyme is not destroyed during the reaction and is used over and over.
Enzymes are biological catalysts that are proteins which accelerate biochemical reactions in living organisms. They were discovered in yeast and are highly specific. Enzymes differ from chemical catalysts in having higher reaction rates under milder conditions and greater substrate specificity. The first enzyme was isolated from jack beans in 1926. Most enzymes are proteins, but some are RNA molecules. Enzymes can exist as single or multiple polypeptide chains and require cofactors like metal ions for activity. The active site is the region where substrates bind for catalysis. Many factors like temperature, pH, and product concentration influence an enzyme's activity rate.
This document provides an introduction to enzymes and enzymology. It defines enzymes as protein catalysts that greatly accelerate biochemical reactions without being consumed. Enzymes work by lowering the activation energy of reactions. The document outlines the basic characteristics and properties of enzymes, including that they contain active sites that bind substrates and facilitate catalysis. It also describes factors that affect enzyme activity such as substrate concentration, temperature, and pH. Overall, the document serves as a high-level overview of the key concepts of enzymes and enzymatic reactions.
Proteins are composed of chains of amino acids linked together by peptide bonds. There are 20 common amino acids that make up proteins. The sequence of amino acids is determined by the DNA sequence. Proteins have four levels of structure: primary, secondary, tertiary, and quaternary. Proteins serve many important functions in the body such as catalysis, muscle contraction, cytoskeleton structure, transport, cell signaling, and immunity.
Introduction of Automation of the Analytical Process
Unit Operations
Specimen identification
Specimen preparation
Specimen delivery
Specimen loading and aspiration
Specimen processing
Sample induction and internal transport
Reagent handling and storage
Chemical reaction phase
Measurement approaches
Signal processing, data handling and process control
Applications of automation in clinical lab
Clinical lab principles, chapter 2 introduction to principles of lab analyses...Ali Raza Ph.D
This document provides an introduction to laboratory safety principles including safety programs, policies, plans, hazards, and precautions. It discusses establishing a formal safety program with documented policies on chemical hygiene, exposure control, tuberculosis control and ergonomics. The major occupational hazards of biological agents, chemicals, fires, electricity and compressed gases are outlined. Precautions for working safely include use of personal protective equipment, proper chemical handling and labeling, and avoiding mouth pipetting.
Lecture 1 introduction to nucleic acid,sims 443, 2021Ali Raza Ph.D
This document discusses nucleic acid techniques used in clinical laboratories. It begins by introducing nucleic acids, their structure, and their roles in storing and transmitting genetic information. It then describes the structures of DNA and RNA, including their nucleotide composition and base pairing. Various nucleic acid analysis techniques are introduced, including polymerase chain reaction (PCR), DNA sequencing, restriction fragment length polymorphism, real-time PCR, electrophoresis, and hybridization. PCR is discussed in detail, outlining its principles, components, steps of DNA denaturation, annealing and extension, and exponential amplification of target DNA sequences.
Chloride is absorbed in the small intestines through an exchange process with bicarbonate as sodium is absorbed. 99% of chloride is reabsorbed in the kidneys, mainly in the proximal tubule, loop of Henle, and collecting duct. Plasma chloride levels vary depending on plasma sodium and bicarbonate concentrations - chloride decreases with increases in sodium or bicarbonate, and increases with decreases in sodium or bicarbonate.
This document discusses calcium, including its functions, absorption, factors affecting absorption, and clinical importance. Some key points:
- Calcium is mainly found in bone and teeth and exists in forms like calcium carbonate and calcium phosphate. About 40% of dietary calcium is absorbed in the small intestine.
- Absorption occurs through both diffusion and active transport, requiring vitamin D and calcium-binding proteins. Absorption is affected by factors like pH, diet composition, age, and hormones.
- In the body, calcium is important for bone and tooth formation, blood coagulation, muscle and nerve function. Normal serum calcium levels are 9-11 mg/dL. Hypercalcemia and hypocalcemia can
1. This document summarizes iron metabolism in the human body, including sources of iron, transport and storage, and clinical aspects of iron deficiency and overload.
2. Iron exists in the body bound to proteins like hemoglobin, myoglobin, cytochromes and iron-requiring enzymes or stored in ferritin and hemosiderin in the liver, spleen and bone marrow. Transferrin transports iron throughout the body.
3. Iron is absorbed in the duodenum and jejunum and either stored in intestinal cells or transported into plasma bound to transferrin. Strict regulation of absorption maintains iron balance in the body.
1) Sodium is a key electrolyte found mainly in extracellular fluid and is primarily associated with chloride as NaCl and NaHCO3.
2) Sodium levels are regulated by the sodium-potassium pump which actively transports 3 Na+ ions out of and 2 K+ ions into cells, maintaining concentration gradients.
3) Abnormal sodium levels can cause clinical conditions like hypernatraemia from decreased body water or hyponatraemia from increased body water dilution.
Potassium -minerals and trace elements Ali Raza Ph.D
This document discusses potassium and its clinical importance. It covers the following key points:
- Potassium is a major intracellular cation, maintaining a concentration gradient between intracellular and extracellular fluid with the help of the sodium-potassium pump.
- Hyperkalemia can result from kidney failure, tissue damage, violent muscle contraction, Addison's disease, or diabetes mellitus. Hypokalemia is usually due to depletion of total body potassium through GI loss, urinary loss, or intracellular shifting.
- Various conditions that can cause hyperkalemia or hypokalemia are described in detail, focusing on the underlying mechanisms of potassium imbalance. Close monitoring of potassium levels is important for managing certain diseases.
Minerals and trace elements introductionAli Raza Ph.D
This document discusses minerals in the human body. It explains that minerals are natural chemical compounds that make up the crystalline structure of tissues and help various body functions, but humans cannot produce them. The body consists of around 29 different mineral elements that are divided into five groups based on their daily requirements and effects of deficiency. Group I elements like carbon, hydrogen, oxygen and nitrogen are components of macromolecules. Group II macro-minerals like sodium, potassium, calcium and phosphorus are required in amounts over 100mg daily and deficiencies can be fatal. Group III trace elements under 100mg daily like iron and zinc are essential and deficiencies cause serious disorders. Group IV elements may be essential but their roles are unknown, while Group V elements
Vitamin A plays an important role in vision, epithelial tissue maintenance, and immune function. It is obtained through foods like cod liver oil, meat, eggs, dairy, and certain fruits and vegetables. The biologically active forms, retinoids, aid in vision through roles in rhodopsin and the visual cycle. Vitamin A supports epithelial tissues and helps prevent keratinization of skin, eyes, and mucous membranes. It also promotes immune response and may have anticancer effects by increasing immune cell receptors. Deficiency can lead to night blindness and xerophthalmia.
This document discusses vitamin K and its functions. It notes that vitamin K includes vitamin K1, K2, and K3. Vitamin K1 is found in plants, K2 is produced by bacteria, and K3 is synthetic. Vitamin K plays an important role in blood clotting by acting as a cofactor for carboxylation of clotting factors in the liver. It is also involved in calcium binding and bone mineralization through carboxylation of proteins in bone. A deficiency in vitamin K can cause bleeding disorders and osteoporosis.
Vitamin E has four types - alpha, beta, gamma, and delta - that differ based on their methyl group position. Alpha-tocopherol has the highest biological activity due to its antioxidant properties. Vitamin E acts as an antioxidant by removing free radicals and preventing lipid peroxidation chains reactions in cell membranes. It protects membranes by reacting with lipid peroxide radicals before they can damage polyunsaturated fatty acids. Deficiencies can cause muscular dystrophy, hemolytic anemia, and hepatic necrosis by increasing oxidative damage to tissues. Vitamin E has clinical uses for conditions like nocturnal muscle cramps, intermittent claudication, and fibrocystic breast disease.
This document discusses vitamin D, its sources, functions, and clinical significance. It covers:
- Dietary sources of vitamin D including fish liver oil, egg yolk, and dairy products.
- The roles of vitamin D in immunity by enhancing natural killer cells and macrophages, and reducing risks of viral infections, cancers, and cardiovascular disease.
- The biologically active form, calcitriol, is synthesized through reactions in the liver and kidneys from provitamins found in plants and skin.
- Vitamin D regulates calcium and phosphate metabolism in bones, kidneys, and intestines, promoting mineralization of bones and intestinal absorption of calcium and phosphate.
- Deficiencies can cause
This document discusses various water-soluble vitamins including vitamins B1, B2, B3, B5, B6, B7, B9, B12, and C. It provides details on the roles, active forms, deficiencies, and food sources of each vitamin. The key points covered include how the vitamins function as enzyme cofactors and in critical metabolic pathways, as well as symptoms that can arise due to deficiencies.
This document classifies vitamins into two main groups: fat-soluble vitamins (A, D, E, K) and water-soluble vitamins. Fat-soluble vitamins are hydrophobic, transported in the blood bound to proteins, and can accumulate in the body and cause toxicity. Water-soluble vitamins are hydrophilic, not readily stored, and excreted from the body so daily intake is important. The water-soluble vitamins include the B vitamins (thiamine, riboflavin, niacin, pantothenic acid, biotin, pyridoxine, folic acid, cobalamin) and vitamin C.
This document discusses vitamins and vitamin deficiencies. It defines vitamins as natural micronutrients that have specific biochemical functions and are required in small amounts. Vitamin deficiencies can cause diseases like scurvy from vitamin C deficiency. The document also discusses cases of vitamin deficiency like avitaminosis from long-term deficiency, hypovitaminosis from inadequate intake, and latent hypovitaminosis where symptoms appear under stress. It notes some vitamins can be destroyed by other substances in foods. Too much vitamin intake can also cause hypervitaminosis. Vitamins have medical uses and are sometimes added to foods through processes like vitaminization, revitaminization, and standardization.
Real-time PCR monitors DNA amplification during PCR cycles, rather than at the end. It uses probes labeled with a fluorescent reporter and quencher; as the target sequence amplifies, more reporters are released, increasing fluorescence measured in real-time by the optical module. This allows quantification of the starting DNA or RNA material. The fluorescence data can be plotted on a curve to visualize amplification over successive cycles.
The document discusses several nucleic acid techniques used in clinical laboratories, including polymerase chain reaction (PCR), reverse transcription PCR (RT-PCR), real-time PCR, electrophoresis, and DNA sequencing. It provides details on how each technique works, such as using thermostable DNA polymerase and primers to amplify specific DNA regions in PCR. RT-PCR is used to amplify RNA by first converting it to cDNA. Real-time PCR detects fluorescence during amplification to quantify levels of target DNA. Electrophoresis separates nucleic acid fragments by size in an electric field in agarose or polyacrylamide gels.
Walmart Business+ and Spark Good for Nonprofits.pdfTechSoup
"Learn about all the ways Walmart supports nonprofit organizations.
You will hear from Liz Willett, the Head of Nonprofits, and hear about what Walmart is doing to help nonprofits, including Walmart Business and Spark Good. Walmart Business+ is a new offer for nonprofits that offers discounts and also streamlines nonprofits order and expense tracking, saving time and money.
The webinar may also give some examples on how nonprofits can best leverage Walmart Business+.
The event will cover the following::
Walmart Business + (https://business.walmart.com/plus) is a new shopping experience for nonprofits, schools, and local business customers that connects an exclusive online shopping experience to stores. Benefits include free delivery and shipping, a 'Spend Analytics” feature, special discounts, deals and tax-exempt shopping.
Special TechSoup offer for a free 180 days membership, and up to $150 in discounts on eligible orders.
Spark Good (walmart.com/sparkgood) is a charitable platform that enables nonprofits to receive donations directly from customers and associates.
Answers about how you can do more with Walmart!"
हिंदी वर्णमाला पीपीटी, hindi alphabet PPT presentation, hindi varnamala PPT, Hindi Varnamala pdf, हिंदी स्वर, हिंदी व्यंजन, sikhiye hindi varnmala, dr. mulla adam ali, hindi language and literature, hindi alphabet with drawing, hindi alphabet pdf, hindi varnamala for childrens, hindi language, hindi varnamala practice for kids, https://www.drmullaadamali.com
Executive Directors Chat Leveraging AI for Diversity, Equity, and InclusionTechSoup
Let’s explore the intersection of technology and equity in the final session of our DEI series. Discover how AI tools, like ChatGPT, can be used to support and enhance your nonprofit's DEI initiatives. Participants will gain insights into practical AI applications and get tips for leveraging technology to advance their DEI goals.
This slide is special for master students (MIBS & MIFB) in UUM. Also useful for readers who are interested in the topic of contemporary Islamic banking.
How to Fix the Import Error in the Odoo 17Celine George
An import error occurs when a program fails to import a module or library, disrupting its execution. In languages like Python, this issue arises when the specified module cannot be found or accessed, hindering the program's functionality. Resolving import errors is crucial for maintaining smooth software operation and uninterrupted development processes.
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Dr. Vinod Kumar Kanvaria
Exploiting Artificial Intelligence for Empowering Researchers and Faculty,
International FDP on Fundamentals of Research in Social Sciences
at Integral University, Lucknow, 06.06.2024
By Dr. Vinod Kumar Kanvaria
How to Build a Module in Odoo 17 Using the Scaffold MethodCeline George
Odoo provides an option for creating a module by using a single line command. By using this command the user can make a whole structure of a module. It is very easy for a beginner to make a module. There is no need to make each file manually. This slide will show how to create a module using the scaffold method.
How to Add Chatter in the odoo 17 ERP ModuleCeline George
In Odoo, the chatter is like a chat tool that helps you work together on records. You can leave notes and track things, making it easier to talk with your team and partners. Inside chatter, all communication history, activity, and changes will be displayed.
A workshop hosted by the South African Journal of Science aimed at postgraduate students and early career researchers with little or no experience in writing and publishing journal articles.
1. Principles of Clinical Enzymology
Course: Clinical Laboratory Principle (SIMS-443)
ZA School of Medical Technology
1
Dr. Ali Raza
Senior Lecturer
SIMS-SIUT
2. Principles of Clinical Enzymology
Introduction:
Enzyme definition
Composition:
Protein part (Apoprotein)
Non-protein(cofactors/coenzymes)
Application
Enzyme Nomenclature
Basic Structure of Enzyme
Homo-multimers
Hetero-multimers
Multiple Forms of Enzymes
Origins of Enzyme Variants: Genetic and Non-genetic
Example of Genetic and Non-genetic
Iso-enzymes: Examples
Specificity of Enzymes 2
3. Enzyme
“ A protein molecule that catalyzes chemical
reactions without itself being destroyed or
altered”
Catalyst:
A substance that increases the rate of a chemical
reaction, but is not consumed or changed by it.
An enzyme is a biocatalyst.
3
5. Enzyme
a) Apoenzyme:
The protein part of an enzyme without the cofactor
necessary for catalysis.
b) Coenzyme:
A Diffusible, heat-stable substance of low molecular
that, when combined with inactive protein called an
Apoenzyme,
helper molecules
5
6. Examples of Coenzyme:
Coenzymes:
Non-protein organic molecules
Many (not all) are vitamins or are derived from vitamins
Thiamine pyrophosphate (TPP)
Flavin adenine dinucleotide (FAD), Biotin
Described as: Cosubstrates or Prosthetic groups.
• Cosubstrates: Coenzymes that bind tightly to a protein, yet will be released and
bind again at some point.(temporarily)
• Prosthetic groups: Enzyme partner molecules that bind tightly or covalently to
the enzyme
Prosthetic groups permanently bond with a protein.
An example of a prosthetic group is heme in hemoglobin, myoglobin,
and cytochrome.
6
8. Enzyme Nomenclature
•The Enzyme Commission EC) of the International
Union of Biochemistry (IUB) developed a rational and
practical basis for identifying enzymes
•The number is prefixed by the letters EC, denoting
Enzyme Commission.
8
9. Nomenclature
All enzymes are assigned to one of six classes,
characterized by the type of reaction they catalyze:
(1) Oxidoreductases
(2) Transferases
(3) hydrolases
(4) Lyases
(5) Isomerases
(6) Ligases
9
14. Nomenclature
Capital letter abbreviations:
A common and convenient practice is to use abbreviations for
the names of certain enzymes
ALT = Alanine Aminotransferase
AST = Aspartate Aminotransferase
LD = Lactate dehydrogenase
CK = Creatine Kinase
G6PD =
14
15. Basic Structure of Enzyme
• All enzyme molecules possess the following level of
structural characteristics of proteins .
• Primary
• Secondary
• Tertiary
• Quaternary
15
16. Basic Structure of Enzyme
• Biological and catalytic activity requires two or more
folded polypeptide chains (subunits) to associate to
form a functional molecule (Quaternary structure).
• Homomultimers: Subunits may be copies of the same
polypeptide chain
E.g.: MM isoenzyme of Creatine kinase,
H4 isoenzyme of Lactate dehydrogenase
• Heteromultimers :
Represent distinct polypeptides.
16
18. Isoenzyme
One of a group of related enzymes catalyzing the same
reaction but having different molecular structures and
characterized by varying physical, biochemical, and
immunological properties.
18
19. Isoenzyme
lactate dehydrogenase is a tetramer made of two
different sub-units,
• H-form
• M-form
These combine in different combinations depending on
the tissue:
LDH1= HHHH
LDH2=HHHM
LDH3=HHMM
LDH4 =HMMM
LDH5=MMMM
19
21. Isoenzyme
• All the forms of a particular enzyme retain the
ability to catalyze its characteristic reaction.
• Have significant quantifiable differences in catalytic
activity.
• These enzyme variants may occur within a single
organ or even within a single type of cell.
21
23. Multiple Forms of Enzymes
Origins of Enzyme Variants could be
• Genetic
• Nongenetic
23
24. Multiple Forms of Enzymes
Genetic Origins of Enzyme Variants
• Due to the existence of more than one gene locus
coding for the structure of the enzyme protein are
called as True isoenzymes
• Many human enzymes (1/3) have more than one
structural gene locus.
24
25. Genetic Origins of Enzyme Variants may be
(a) Genes at the different loci have undergone modifications
during the course of evolution
(b) Isoenzymes are not necessarily closely linked on one
chromosome; they are often located on different
chromosomes
25
26. Genetic Origins of Enzyme Variants may be
(c) Oligomeric enzymes and consist of molecules made up of
subunits.
The association of different types of subunits in various
combinations gives rise to a range of active enzyme
molecules.
When the subunits are derived from different structural genes,
either multiple loci or multiple alleles, the hybrid molecules so
formed are called hybrid isoenzymes.
26
27. Genetic Origins of Enzyme Variants
Enzymes of clinical importance that exist as
isoenzymes because of the presence of multiple gene
loci are
Lactate dehydrogenase
Creatine kinase
alpha-amylase
Alkaline phosphatase
27
28. Nongenetic Causes of Multiple Forms of Enzymes
• Posttranslational modification of enzyme molecules
give rise to multiple forms, known as isoforms
• Modification of the residues in the polypeptide
chains of enzyme molecules
• Changes affecting non-protein components of
enzyme molecules may also contribute to
molecular heterogeneity.
28
29. Modification of the residues in the polypeptide chains
of enzyme molecules includes
• Acylation
• Alteration of carbohydrates side chain
• Partial cleavage of chain
• De-amination
• Sulfhydryl Oxidation
• Phosphorylation
• Association with other proteins
29
31. Example of Nongenetic Causes of Isoforms
• Removal of Amide groups accounts for Amylase and Carbonic
Anhydrase
• Adenosine deaminase, Acid phosphatase, Phosphoglucomutase,
contain sulfhydryl groups,
• susceptible to oxidation resulting in variant enzyme molecules
with altered molecular charge.
31
32. Example of Nongenetic Causes of Isoforms
Many enzymes are glycoproteins, and variations in carbohydrate
side chains are a common cause of non homogeneity
of preparations of these enzymes.
N-acetyl neuraminaic acid (sialic acid)
32
33. Example of Nongenetic Causes of Isoforms
• N-acetylneuraminic acid (sialic acid),
• are strongly ionized and consequently have a profound effect
on some properties of enzyme molecules.
• For example, removal of terminal sialic acid groups from human
liver and/or bone alkaline phosphatase with neuraminidase
greatly reduces the electrophoretic heterogeneity of the
enzyme.
33
34. Distribution of isoenzymes
• Not uniform throughout the body,
• Wide variations in the isoenzymes activity are found
at the organ, cellular, and subcellular levels.
• Tissue-specific differences are also found in the
distributions of some isoforms that are not due to
the existence of multiple gene loci.
34
35. Changes in lsoenzyme Distribution During
Development and Disease
• Multiple gene loci and their resultant isoenzymes
provide a means for the adaptation of metabolic
patterns to the changing needs of different organs
and tissue in the course of normal development or
in response to environmental change.
• Pathological conditions also are known to be
associated with alterations in the activities of
specific isoenzymes.
35
36. Examples of Changes in lsoenzyme
• The patterns of several sets of isoenzymes change
during normal development in tissue.
• During embryonic development of skeletal muscle,
LD and CK, progressively increase until the sixth
month of intrauterine life
• In early fetal development, three Aldolase
isoenzymes, A, B, and C, have been detected in
extracts of liver.
• At birth-as in the adult liver aldolase B is the
predominant isoenzyme. 36
37. Progressive muscular dystrophies appear to involve a
failure of the affected tissues to mature normally or to
maintain a normal state.
The distributions of isoenzvmes of aldolase., LD,. and
CK in the muscles of patients with progressive muscular
dystrophy have been found to be similar to those in the
earlier stages of development of fetal muscle.
The isoenzyme abnormalities in dystrophic muscle
have been interpreted as a failure to reach or maintain
a normal degree of differentiation.
37
38. Differences in Properties Between Multiple Forms of Enzymes
Genetic vs NonGenetic
The structural differences between the multiple forms of an
enzyme give rise to greater or lesser differences in
physicochemical properties
(1) Electrophoretic mobility,
(2) Resistance to inactivation
(3) Solubility, or in catalytic characteristics,(Ratio of reaction
with substrate analogs or response to inhibitors)
38
39. Differences in Properties Between Multiple Forms of Enzymes
Genetic vs NonGenetic
Genetic
Isoenzymes differ in catalytic properties
• molecular activity,
• K,, values for substrate(s),
• sensitivity to various inhibitors,
• relative rates of activity with substrate
analogs.
Immunological cross-reaction is not
uncommon
Differences in resistance to denaturation are
commonly found between true isoenzymes
NonGenetic
(posttranslational modifications)
• Have similar catalytic properties.
• Common antigenic determinants
39
40. Specificity of Enzymes
One of the properties of enzymes that makes them so important as diagnostic
and research tools is the specificity they exhibit relative to the reactions they
catalyze.
In general, there are four distinct types of specificity:
1. Absolute specificity - the enzyme will catalyze only one reaction.
2. Group specificity - the enzyme will act only on molecules that have specific
functional groups, such as amino, phosphate and methyl groups.
3. Linkage specificity - the enzyme will act on a particular type of chemical
bond regardless of the rest of the molecular structure.
4. Stereochemical specificity - the enzyme will act on a particular steric or
optical isomer
40
41. Enzyme Denaturation
• The catalytic activity of an enzyme molecule
depends on the integrity of its structure.
• Any disruption of the structure is accompanied
by a loss of activity, a process known
as denaturation.
41
42. Enzyme Denaturation
The partial or total alteration of the structure
of a protein, without change in covalent
structure, by the action of certain physical
procedures (heating, agitation) or chemical
agents.
42
43. Enzyme Denaturation
• Denaturation is either reversible or irreversible.
• Prolonged or severe denaturing conditions result in
an irreversible loss of activity.
• Denaturing conditions include
(1) Elevated Temperatures
(2) Extremes of pH
(3) Chemical addition
43
44. Enzyme Denaturation
(1) Elevated Temperatures:
a) At room temperature
b) Above 60 C
• Polymerase is an exception retain activity (90C)
• Storage: Low temperatures are used to preserve
enzyme activity
44
45. Enzyme Denaturation
2. Extremes of pH:
• Cause unfolding of enzyme molecular structures
• Should be avoided when preserving enzyme
samples.
45
46. Enzyme Denaturation
(3) Chemical Addition:
• Addition of chemicals disrupts
• hydrogen bonds and
• hydrophobic interactions
• Exposure of enzymes to strong solutions of these
reagents results in inactivation.
• Example: Urea
46
47. Enzymes as Catalysts
• Enzymes are protein catalysts of biological origin.
• Virtually, all chemical reactions that take place in
living matter are catalyzed by specific enzymes.
• Life itself is regarded as an integrated series of
enzymatic reactions and some diseases as a
derangement of the normal pattern of metabolism.
47
48. Enzyme Efficiency
• Biologically, a given number of enzyme molecules convert
an enormous number of substrate molecules to products
within a short time.
• Increased amounts of enzymes in the blood stream is
easily detected
• Amount of enzyme protein released from damaged cells
is small compared with the total level of non-enzymatic
proteins in blood.
• A particular enzyme is recognized by its characteristic
effect on a given chemical reaction
48
49. Specificity and the Active Center of Enzyme
Interaction between the enzyme and its substrate
involves the combination of one molecule of enzyme
with one substrate molecule (or two, bisubstrate
reactions).
Active Center :
The reaction involves the attachment of the substrate
molecule to a specialized region of the enzyme
molecule, its Active Center.
49
50. • Various groups are important in substrate binding are
brought together at the active center, and there the
processes of activation and transformation of the
substrate take place.
• The composition and spatial arrangement of the
active center also form the basis for the specificity of
an enzyme.
50
51. Active Site
The active site of an enzyme is/are
1. Relatively small (<5% of the total amino acids)compared
with the total volume of the enzyme molecule
2. 3-D structures are formed as a result of the overall
tertiary structure of the protein.
• This results from the amino acids and co-factors in
the active site of an enzyme being spatially structured
in an exact 3D relationship with respect to one
another and the structure of the substrate molecule.
51
52. The active site of an enzyme is/are
The attraction between the enzyme and its substrate molecules
is non-covalent binding.
Physical forces used in this type of binding include
(1) Hydrogen bonding
(2) electrostatic and hydrophobic interactions
(3) Van der Waals forces.
4. Occur in clefts and crevices in the protein, excludes bulk
solvent and reduces the catalytic activity of the enzyme.
5. The specificity of substrate binding is a function of the exact
special arrangement of atoms in the enzyme active site that
complements the structure of the substrate molecule.
52
55. Enzyme Kinetics
Basic Enzyme Reactions
Enzymes are catalysts and increase the speed of a chemical reaction without
themselves undergoing any permanent chemical change.
They are neither used up in the reaction nor do they appear as reaction products.
The basic enzymatic reaction can be represented as follows
where E = the enzyme catalyzing the reaction,
S = the substrate, the substance being changed,
P = the product of the reaction.
55
56. Energy Levels
The energy of activation:
• The quantity of energy is needed by chemical reactions to proceed.
• Magnitude of the activation energy which determines just how fast
the reaction will proceed.
• Enzymes lower the activation energy for the reaction they are
catalyzing.
56
57. The energy of activation
The enzyme is thought to reduce the "path" of the reaction. This shortened path
would require less energy for each molecule of substrate converted to product.
Given a total amount of available energy, more molecules of substrate would be
converted when the enzyme is present (the shortened "path") than when it is
absent. Hence, the reaction is said to go faster in a given period of time
57
58. The energy of activation
The Enzyme Substrate Complex
A theory to explain the catalytic action of enzymes was proposed
by the Swedish chemist Savante Arrhenius in 1888.
He proposed that the substrate and enzyme formed some
intermediate substance which is known as the enzyme substrate
complex.
The reaction can be represented as:
58
59. The energy of activation
The Enzyme Substrate Complex
At Yale University, Kurt G. Stern observed spectral shifts in catalase as the
reaction it catalyzed proceeded.
This experimental evidence indicates that the enzyme first unites in some
way with the substrate and then returns to its original form after the
reaction is concluded.
59
60. Enzyme kinetics
• The quantitative measurement of the (a) Rates of enzyme-
catalyzed reactions and (b) Factors that affect these rates.
• Rate of a chemical reactions:
Number of molecules of reactant(s) are converted into
product(s) in a specified time.
• Reaction rate is dependent on the
(a) Concentration of the chemicals
(b) Rate Constants of the reaction
60
62. • Enzymes act through the formation of an enzyme-substrate
(ES) complex, a molecule of substrate is bound to the active
center of the enzyme molecule.
• The binding process transforms the substrate molecule to its
activated state.
• ES complex breaks down to give the Products (P) and free
Enzyme (E):
• Activation energy takes place without the addition of external
energy so that the energy barrier to the reaction is lowered
Enzyme Kinetics
62
63. • Analytically, several enzymatic reactions may be linked
together to provide a means of measuring the activity of the
first enzyme or the concentration of the initial substrate in
the chain.
• When a secondary enzyme-catalyzed reaction, known as an
indicator reaction, is used to determine the activity of a
different enzyme, the primary reaction catalyzed by the
enzyme to be determined must be the rate-limiting step.
• Conditions are chosen to ensure that the “ rate of reaction
catalyzed by the indicator enzyme is directly proportional to
the rate of product formation in the first reaction.
Enzyme Kinetics
63
64. The International Unit (U)of Enzyme Activity
The EC of the IUB proposed
“ The quantity of enzyme that catalyzes the reaction of 1 μmol of
substrate per minute “
• Expressed in terms of U/L
• The catalytic activity of an enzyme is independent of the
volume, the unit used for enzymes is usually turnover per unit
time, expressed in katal (kat, mol s–1).
• The international unit U is still more commonly used
(μmol turnover min–1)
1 U = 10-6 mol/60s
64
66. Factors Governing the Catalyzed Reactions
Factors that affect the rate of enzyme-catalyzed reactions
include
a) Enzyme concentration
b) Substrate concentration
c) pH
d) Temperature
e) Presence of Inhibitors
f) Presence of Activators
g) Coenzymes
h) Prosthetic groups
66
67. A- Enzyme Concentration
• Overall rate of the reaction is proportional to the [ES complex]
• Addition of more enzyme molecules to the reaction system
increases the conc. of the ES complex and the overall rate of
reaction.
• This increase accounts for the rate of reaction being proportional
to the concentration of enzyme present in the system
• Basis for the quantitative determination of enzymes by
measurement of reaction rates.
67
68. A- Enzyme Concentration
• As the amount of enzyme is
increased, the rate of reaction
increases.
• If there are more enzyme
molecules than are needed,
adding additional enzyme will
not increase the rate.
• So, Reaction rate increases as
enzyme conc. increases but
then it levels off.
68
69. B- Substrate Concentration
• Dependence of reaction rate on enzyme conc. under excess
substrate is present,
• Formation of an ES complex also accounts for the hyperbolic
relationship between reaction velocity and substrate
concentration
69
73. First Order Reaction
At lower Substrate concentrations, the active sites on
most of the enzyme molecules are not filled.
Higher concentrations cause more collisions
between the molecules. The rate of reaction increases
(First order reaction).
Rate of the reaction is proportional and dependent
on the substrate concentration
73
74. Zero Order Reaction
• The maximum velocity of a reaction is reached when the
active sites are almost continuously filled.
• Increased substrate conc. after this point will not increase
the rate.
• At high substrate concentrations, the reaction rate is known
as zero-order reaction and is independent of substrate
concentration.
74
75. Maximal Velocity (Vmax)
• Reflects how fast the enzyme can catalyze the reaction
low Vmax enzymes
high Vmax enzymes
75
76. Michaelis Constant (Km)
• Substrate conc. that gives the enzyme one-half of its Vmax
low Km enzymes
high Km enzymes
https://www.chem.wisc.edu/deptfiles/genchem/netorial/modules/biomolecules/modules/enzymes/enzyme4.htm
76
77. Michaelis Constant (Km)
• Enzymes have varying tendencies (affinities) to bind their
substrates.
High Km
• A lot of substrate must be present to saturate the enzyme
• Enzyme has low affinity for the substrate.
Low Km
• A small amount of substrate is needed to saturate the enzyme,
• Enzyme has high affinity for substrate.
77
78. Km and its significance
Helps in determines
• the affinity of an enzyme for its substrate,
E.g: low the Km, higher is the affinity for substrate
• True substrate conc. for the enzyme.
Zero-order kinetics are maintained if the substrate is present
in large excess 10 - 100 times value of Km.
[S] = 10 x Km, [v is ~ 91% of the theoretical Vmax. ]
The majority of enzymes Km are 10-5 to 10-3 mol/L
78
79. Km is Specific and constant for a given enzyme under
defined conditions of time , temperature and pH
79
80. Substrate Concentration
Km, is reserved for the experimentally determined value
of [S] at which the reaction proceeds at one half of its
maximum velocity (v = Vmax/2).
80
81. The Michaelis-Menten
• It is a quantitative description of the relationship among
the rate of an enzyme-catalyzed reaction [v], the
concentration of substrate [S] and two constants, V max
and km
v = Reaction Rate
V max = Maximum Reaction Rate
S = Substrate Concentration
Km = The Michaelis-Menten Constant
81
82. Draws back of The Michaelis-Menten
• it is straightforward to set up an experiment to determine the
variation of v with [S]
• Hyperbolic curves: The exact value of Vmax is not easily
determined.
• Deviation from ideal behavior : Many enzymes at high substrate
conc. indeed may be inhibited by excess substrate
82
84. Line weaver- Burk plot
(Double Reciprocal )
A Linear Form of the Michaelis-Menten Equation Is Used to
determine
• km
• V max
84
85. Lineweaver- Burk plot
• Plot of 1/vi as y as a function of 1/[S] as x therefore gives a
straight line
• whose y intercept is 1/ V max and whose slope is km/V max.
85
86. Lineweaver- Burk plot
With intercepts at l/Vmax on the ordinate (Y-axis) and -
1/K,, on the abscissa(X-axis).
86
87. Km
• It is now routine practice to determine kinetic constants,
such as Km and Vmax using a software package.
• When setting up methods of enzyme assay, it is necessary to
(1) Explore the relationship between reaction velocity and
substrate concentration over a wide range of concentrations
(2) Determine Km
(3) Detect any inhibition at high substrate Conc.
87
88. The optimal concentrations of substrate cannot be
used
(a) Substrate limited solubility
(b) substrate inhibits the activity of another enzyme
88
89. Two-Substrate Reactions
(Bisubstrate)
• Bisubstrate reactions are important in clinical enzymology
• The second substrate is a specific coenzyme,
Reduced Nicotinamide-adenine dinucleotide (NADH)
Reduced NAD Phosphate (NADPH)
Examples:
• Dehydrogenases
• Aminotransferases
89
92. Two-Substrate Reactions (Bisubstrate)
• The concentrations of both substrates affect the rates
of two-substrate reactions.
• Values of Km and Vmax, for each substrate are derived
from experiments
• Concentration of the first substrate is held at
saturating levels, whereas the concentration of the
second substrate is varied, and vice versa.
92
93. Two-Substrate Reactions (Bisubstrate)
• The choice of substrate concentrations is limited by such
considerations as the
(1) solubility of the substrates,
(2) viscosity and high initial absorbance of conc. solutions,
(3) relative costs of the reagents.
93
94. Two-Substrate Reactions (Bisubstrate)
The selection of appropriate substrate concentrations is
only one of the factors to be considered in formulating an
optimal assay system for the measurement of specific
enzyme activity.
94
95. Two-Substrate Reactions
(Bisubstrate)
• Critical choices must also be made with respect to other,
frequently interdependent factors that affect reaction
rate, such as
• Concentrations of Activators
• Nature and pH of the Buffer system.
95
96. C- pH
• Enzymatic Activity has been observed at pH values as
low as 1.5 (Pepsin)
as high as 10.5 (ALP)
• Many of the enzymes in blood plasma show
maximum activity in vitro in the pH range from 7 - 8.
• Optimal pH for a given forward reaction may be
different from the optimal pH found for the
corresponding reverse reaction.
96
98. pH
The pH-dependence curve is a result of a
(a) Ionization of the substrate
(b) The extent of dissociation of certain key amino acid
side chains in the protein molecule, both at the
active center and elsewhere in the molecule.
• Both pH and ionic environment will also have an
effect on the 3D conformation of the protein
• Enzyme activity to such an extent that enzymes may
be irreversibly denatured at extreme values of pH.
98
99. pH
• The effects of pH on enzyme reactions is control by
buffer solutions.
• The buffer system must be capable of counteracting
the effect of adding the specimen to the assay system
• E.g.: Serum itself is a powerful buffer
• Effects of acids or bases formed during the reaction
(e.g., formation of fatty acids by the action of lipase).
99
102. d - Temperature
• The rate of an enzymatic reaction is proportional to its reaction
temperature.
• Reaction rate increases with temperature to a max level,
then abruptly declines with further increase of temperature
102
103. Optimal temperature for enzyme activity
• Effects of the increased rate of the catalyzed reaction
and more rapid enzyme inactivation as the temperature
increases account for the existence of an apparent
optimal temperature for enzyme activity
103
104. D- Temperature
•A coefficient expressing the relation between a change in a
physical property and the change in temperature that causes it.
•Most animal enzymes rapidly become denatured at above 40C
• The temperature coefficient (Q10): The factor by which the
rate of a biologic process increases for a 10 °C increase in
temperature.
• For most enzymatic reactions, values of Q, (the
relative reaction rates at two temperatures differing
by 10 C) vary from 1.7 to 2.5.
104
105. Temperature
• The initial rate of reaction measured instantaneously
will increase with a rising temperature.
• A finite time is needed to allow the enzyme solution
to reach temperature equilibrium and to permit the
formation of a measurable amount of the product.
• During this period the enzyme is undergoing thermal
inactivation and denaturation a process that has a
very large temperature coefficient for most enzymes
and thus becomes virtually instantaneous at
temperatures of 60 "C to 70 "C.
105
106. Temperature
• An enzyme thermal inactivation is influenced by a
number of factors
(1) presence of substrate and its concentration,
(2) pH,
(3) Nature and ionic strength of the buffer.
106
107. Temperature
• Individual enzymes vary
• stability characteristics
• storage conditions
• Storage of serum samples at low temperatures is
necessary to minimize loss of enzyme activity while
awaiting analysis.
• Amylase is stable at room temperature (22-25C) for 24h
• Acid Phosphatase is exceedingly unstable, even when
refrigerated, unless kept at a pH below 6.0.
107
108. • Few enzymes are inactivated at refrigerator temperatures
• Example
liver-type isoenzyme of lactate dehydrogenase ( LD-5) =
less stable at lower temperatures.
• As a result, sera for LD determinations should be kept at
room temperature and not refrigerated.
108
109. E-Inhibitors and Activators
• Modifiers : their presence may reduces or increase the reaction rate
Inhibitors
Activators
• Small molecules
• Vary in specificity = Modifiers that exert similar effects on a wide
range of different enzymatic reactions at one extreme, to substances
that affect only a single reaction.
• Examples of nonspecific enzyme inhibitors
• Reagents, such as strong acids or multivalent anions and cations
that denature or precipitate proteins, destroy enzyme activity
109
110. Inhibitors
• Chemicals that reduce the rate of enzymic reactions
• Specific and work at low concentrations
• Block the enzyme but they do not usually destroy it
• Many drugs and poisons are inhibitors of enzymes in
the nervous system
• Inhibitors of the catalytic activities of enzymes provide
both pharmacologic agents and research tools for
study of the mechanism of enzyme action.
110
111. Inhibitors and Activators
• The activity of some enzymes depends on the presence of
particular chemical groups in the active center.
• E.g.: Reduced sulfhydryl(-SH) groups
• Inhibitors alter these groups of enzymes.
• E.g., oxidants of SH groups
111
112. Inhibitors and Activators
• Enzyme activation or inhibition are caused by
Interaction between the modifier and a non-enzymatic
component of the reaction system such as the substrate
• E.g.: Mg2+ combining with adenosine triphosphate (ATP)
to form Mg-ATP, required substrate for the CK reaction.
• In most cases, the modifier combines with the enzyme itself
in a manner analogous to the combination of enzyme and
substrate.
112
113. Enzyme Inhibition Classification
• Inhibitors can be classified based upon their site of
action on the enzyme,
• Chemically modify the enzyme
• Influence the kinetic parameters
113
114. Inhibition of Enzyme Activity
Inhibitors are classified as
• Reversible
• Irreversible
114
115. The effect of enzyme inhibition
• Irreversible inhibitors: Combine with the functional
groups of the amino acids in the active site
• Reversible inhibitors: These can be washed out of the
solution of enzyme by dialysis.
Applications of inhibitors
• Poisons snake bite, plant alkaloids and nerve gases
• Medicine antibiotics, sulphonamides, sedatives and
stimulants
• Negative feedback: end point or end product inhibition
115
116. Types of Enzyme Inhibition
• Competitive Enzyme Inhibition
• Non Competitive Enzyme Inhibition
• Uncompetitive Enzyme Inhibition
116
118. Reversible Inhibition
Reversible inhibition: Activity of the enzyme is
restored fully when the inhibitor physically is
removed from the system.
This type of inhibition is characterized by the
existence of an equilibrium between enzyme (E), and
inhibitor (I)
K, (the inhibitor constant), is a measure of the
affinity of the inhibitor for the enzyme,
118
119. Competitive inhibitor
• structural analog of the substrate: binds to the enzvme at the
substrate-binding site.
• Breakdown into products does not take place.
• When the process of inhibition is fully competitive, the
enzyme combines with either the substrate or the inhibitor,
but not with both simultaneously
119
120. Competitive Inhibitor
At low substrate concentrations, the binding of substrate
is reduced because some enzyme molecules are combined
with the inhibitor.
Conc. Of [ES] and the overall reaction velocity are reduced,
Km is increased.
At high substrate concentrations At high [S], all the
enzyme molecules combine to form ES so that
Vmax, is unaffected by the inhibitor.
120
121. A competitive inhibitor
• Structure similar to substrate(Structural Analog)
• Occupies active site
• Competes with substrate for active site
• Has effect reversed by increasing substrate Conc.
• Vmax remains same
• Km is increased
121
123. Competitive Inhibitor (C)
These characteristics of competitive inhibition are
demonstrated in the Line weaver-Burk plot
123
124. Competitive Inhibitor
• In two-substrate reactions, high concentrations of the
second substrate may compete with the binding of the
first substrate.
• Competitive inhibition contributes to the
• Reduction rate of an enzymatic reaction with time
• Nonlinearity of reaction progress curves.
124
125. Non-Competitive Inhibitor
• Structurally different from the substrate.
• Bind at a site on the enzyme other than the substrate-
binding site;
• No competition exists between
• Inhibitor and substrate
• enzyme-substrate-inhibitor (ESI) complex forms.
• Attachment of the inhibitor to the enzyme does not alter
the affinity of the enzyme for its substrate (K is unaltered),
•ESI complex does not break down to provide products.
125
126. Noncompetitive inhibitor
bind enzymes at sites distinct from the substrate-binding
site
• Generally bear little or no structural resemblance
to the substrate
• Binding of the inhibitor does not affect binding of
substrate
• Formation of both EI and EIS complexes is
therefore possible
• The enzyme-inhibitor complex can still bind
substrate, its efficiency at transforming substrate
to product, reflected by Vmax, is decreased
126
129. Noncompetitive inhibitor
Because the substrate does not compete with the
inhibitor for binding sites on the enzyme molecule,
an increase in the substrate concentration
does nut overcome the effect of a noncompetitive
inhibitor.
Thus Vmax is reduced in the presence
Km is not altered
129
131. Noncompetitive inhibitor (NC)
• In the presence of a competitive
inhibitor,
Vmax can still be reached if sufficient
substrate is available, onehalf Vmax
requires a higher [S] than before and
thus Km is larger.
• With noncompetitive inhibition,
enzyme rate (velocity) is reduced
for all values of [S], including Vmax
and onehalf Vmax but Km remains
unchanged
131
132. Examples of Non-Competitive Inhibitor (NC)
• Cyanide inhibits cytochrome oxidase
• Fluoride inhibits Enolase and hence glycolysis
• Iodoacetate inhibits enzymes having SH groups in their active
sites
• BAL ( British Anti Lewisite, dimercaprol) is used as an antidote
for heavy metal poisoning
• Heavy metals act as enzyme poisons by reacting with the SH
groups
• BAL has several SH groups with which the heavy metal ions
bind and thereby their poisonous effects are reduced
132
133. Uncompetitive Inhibition (UC)
Uncompetitive inhibition: Due to combination of the
inhibitor with the ES complex and is more common in
two-substrate reactions, in which a ternary ESI
complex forms after the first substrate combines with
the enzyme.
parallel lines are obtained when plots of 1/v against
l/[S] with and without the inhibitor are compared
Both Km, and Vmax,, are decreased.
133
134. Uncompetitive Inhibition (UC)
Inhibitor binds to enzymesubstrate complex
• Both Vmax and Km are decreased
• e.g ; Inhibition of placental alkaline phosphatase
(Regan isoenzyme) by Phenylalanine
134
136. Irreversible inhibition
• Render the enzyme molecule inactive by covalently and
permanently modifying a functional group required for
catalysis.
• Its effect is progressive with time, becoming complete if the
amount of inhibitor present exceeds the total amount of
enzyme.
• The rate of the reaction between enzyme and inhibitor is
expressed as the fraction of the enzyme activity that is
inhibited in a fixed time by a given concentration of
inhibitor.
• The velocity constant of the reaction of the inhibitor with
the enzyme is a measure of the effectiveness of the
inhibitor. 136
137. Irreversible inhibition
• Antienzymes: Important category of irreversible enzyme
inhibition
• E.g.: Trypsin inhibitors
• These are proteins that bind to trypsin irreversibly,
nullifying its proteolytic activity. E.g: Alpha 1-globulin
• Proteolysis inhibitors : Present in plasma prevent the
accumulation of excess thrombin / coagulation enzymes,
keeping the coagulation process under control.
137
138. Inhibition by Antibodies
• Enzyme-antibody complex has no effect on catalytic
activity
• Reaction of the enzyme and antibody reduces or stops
enzymatic activity.
• b/c antibody molecule (a)restricts access of the
substrate molecules to the active center by steric
hindrance
(b) completely masks the substrate-binding site
(c)induced conformational change in the enzyme 138
139. F- Enzyme Activation
• Activators increase the rates of enzyme-catalyzed reactions
by a variety of mechanisms of activation.
• For example: enzymes contain metal ions as an integral
part of their structures to stabilize tertiary and quaternary
protein structures.
• Removal of divalent metal ions by ethylene diamine tetra
acetic acid (EDTA) solution is accompanied by
conformational changes with inactivation of the enzyme.
• The enzyme often is reactivated by adding the ion to the
reaction mixture.
139
140. F- Enzyme Activation
• Enzyme may be deficient in the ion so that addition of the
ion increases the reaction rate or indeed may be essential
for the reaction to take place.
• E.g.: Phosphate transfer enzymes (Creatine kinase) require
Mg2+ Ions.
• Activating Cations : Mn2+, Fez+, Ca2+, Zn2+, and K+.
• Activating Anions : Amylase functions at its maximal rate
in monovalent anions CI-, Br- or NO3-
140
141. F- Enzyme Activation
• Some enzymes require the obligate presence of two
activating ions.
• K+ and Mg2+ are essential for Pyruvate Kinase,
• Mg2+ and Zn" are required for ALP activity.
141
143. Coenzymes
• Small organic molecules
• Smaller than the enzyme proteins
• E.g: NAD, and NADP, are classified as coenzymes and are specific substrates in two-
substrate reactions.
• Their effect on the rate of reaction follows the Michaelis-Menten Pattern of
dependence on substrate concentration.
• Coenzymes such as NAD and NADP are bound only momentarily to the enzyme
during the course of reaction, as isthe case for substrates in general.
• Therefore no reaction takes place unless the appropriate coenzyme is present in the
solution.
143
144. Cofactors
• In contrast to these entirely soluble coenzymes, some
coenzymes are more or less permanently bound to the
enzyme molecules, where they form part of the active
center and undergo cycles of chemical change during
the reaction.
Prosthetic groups :
• Most common cofactor are also metal ions
• If tightly bound, the cofactors are called prosthetic groups
• The prosthetic group may be organic (such as a
vitamin, sugar, or lipid) or inorganic (such as a metal
ion), but is not composed of amino acids.
144
145. Prosthetic Groups
• The active holoenzyme results from the combination of the inactive apoenzyme with the
prosthetic group.
• An example of a prosthetic group is pyridoxal phosphate (P-5'-P), a component of AST and ALT.
• The P-5'4' prosthetic group undergoes a cycle of conversion of the pyridoxal moiety to
pyridoxamine and back again during the transfer of an amino group from an amino acid to an oxo-
acid.
Prosthetic groups, such as activators with a structural role, do not usually have to be added to elicit
full catalytic activity of the enzyme unless previous treatment has caused the prosthetic group to be
lost from some enzyme molecules.
both normal and pathological serum samples contain appreciable amounts of apo-
aminotransferases,which is converted to the active holoenzymes by a suitable period of incubation
with P-5'-P.
145
146. pH
• Buffers have their maximum buffering capacity
close to their pK, (-log ionization constant K,) values,
• A buffer system should be chosen with a pKa, value
within 1 pH unit of the desired pH of the assay.
146